These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22261808)

  • 1. Activation of PI3K signaling in Merkel cell carcinoma.
    Nardi V; Song Y; Santamaria-Barria JA; Cosper AK; Lam Q; Faber AC; Boland GM; Yeap BY; Bergethon K; Scialabba VL; Tsao H; Settleman J; Ryan DP; Borger DR; Bhan AK; Hoang MP; Iafrate AJ; Cusack JC; Engelman JA; Dias-Santagata D
    Clin Cancer Res; 2012 Mar; 18(5):1227-36. PubMed ID: 22261808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the PI3K/AKT pathway in Merkel cell carcinoma.
    Hafner C; Houben R; Baeurle A; Ritter C; Schrama D; Landthaler M; Becker JC
    PLoS One; 2012; 7(2):e31255. PubMed ID: 22363598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
    Iwasaki T; Matsushita M; Nonaka D; Kuwamoto S; Kato M; Murakami I; Nagata K; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2015 Feb; 46(2):210-6. PubMed ID: 25466966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma.
    Harms PW; Vats P; Verhaegen ME; Robinson DR; Wu YM; Dhanasekaran SM; Palanisamy N; Siddiqui J; Cao X; Su F; Wang R; Xiao H; Kunju LP; Mehra R; Tomlins SA; Fullen DR; Bichakjian CK; Johnson TM; Dlugosz AA; Chinnaiyan AM
    Cancer Res; 2015 Sep; 75(18):3720-3727. PubMed ID: 26238782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
    Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
    Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
    Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
    Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.
    Harms KL; Lazo de la Vega L; Hovelson DH; Rahrig S; Cani AK; Liu CJ; Fullen DR; Wang M; Andea AA; Bichakjian CK; Johnson TM; Tomlins SA; Harms PW
    JAMA Dermatol; 2017 Jun; 153(6):505-512. PubMed ID: 28403382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts.
    Fang B; Kannan A; Zhao S; Nguyen QH; Ejadi S; Yamamoto M; Camilo Barreto J; Zhao H; Gao L
    Sci Rep; 2020 Jun; 10(1):8867. PubMed ID: 32483262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.
    Harms KL; Zhao L; Johnson B; Wang X; Carskadon S; Palanisamy N; Rhodes DR; Mannan R; Vo JN; Choi JE; Chan MP; Fullen DR; Patel RM; Siddiqui J; Ma VT; Hrycaj S; McLean SA; Hughes TM; Bichakjian CK; Tomlins SA; Harms PW
    Clin Cancer Res; 2021 May; 27(9):2494-2504. PubMed ID: 33547200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
    Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
    J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.
    Beaver JA; Gustin JP; Yi KH; Rajpurohit A; Thomas M; Gilbert SF; Rosen DM; Ho Park B; Lauring J
    Clin Cancer Res; 2013 Oct; 19(19):5413-22. PubMed ID: 23888070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal.
    DeCoste RC; Carter MD; Pasternak S; Fleming KE; Gaston D; Legge A; Ly TY; Walsh NM
    Hum Pathol; 2021 Nov; 117():31-41. PubMed ID: 34391748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.
    Waltari M; Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Int J Cancer; 2011 Aug; 129(3):619-28. PubMed ID: 20949558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.
    Laude HC; Jonchère B; Maubec E; Carlotti A; Marinho E; Couturaud B; Peter M; Sastre-Garau X; Avril MF; Dupin N; Rozenberg F
    PLoS Pathog; 2010 Aug; 6(8):e1001076. PubMed ID: 20865165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
    Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
    J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
    Wong SQ; Waldeck K; Vergara IA; Schröder J; Madore J; Wilmott JS; Colebatch AJ; De Paoli-Iseppi R; Li J; Lupat R; Semple T; Arnau GM; Fellowes A; Leonard JH; Hruby G; Mann GJ; Thompson JF; Cullinane C; Johnston M; Shackleton M; Sandhu S; Bowtell DD; Johnstone RW; Fox SB; McArthur GA; Papenfuss AT; Scolyer RA; Gill AJ; Hicks RJ; Tothill RW
    Cancer Res; 2015 Dec; 75(24):5228-34. PubMed ID: 26627015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic profiles of different subsets of Merkel cell carcinoma show links between combined and pure MCPyV-negative tumors.
    Carter MD; Gaston D; Huang WY; Greer WL; Pasternak S; Ly TY; Walsh NM
    Hum Pathol; 2018 Jan; 71():117-125. PubMed ID: 29079179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
    Schrama D; Sarosi EM; Adam C; Ritter C; Kaemmerer U; Klopocki E; König EM; Utikal J; Becker JC; Houben R
    Int J Cancer; 2019 Aug; 145(4):1020-1032. PubMed ID: 30873613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.